Park Medi World Ltd (PARKHOSPS) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Park Medi World Ltd on NSE and BSE, with an AI summary of each filing.
Schedule of Analyst/Investor Meeting scheduled on November 11, 2026
Intimation · 11 Nov 2026, 10:00 am
Park Medi World Schedules Q2 & H1 FY27 Earnings Call on 11th Nov'26 Park Medi World Limited will host an earnings conference call for analysts and institutional investors on 11th Nov'26 at 10:00 AM IST to discuss operational and financial performance for Q2 & H1 FY27 (period ended 30th Sep'26). Results will be announced on 9th Nov'26, alongside the investor presentation filing. Senior management participants include MD Dr. Ankit Gupta, Whole Time Director & CEO Dr. Sanjay Sharma, Group CFO Rajesh Sharma, and Chief Strategy Officer Sudesh Sharma.
PARK MEDI WORLD LIMITED has informed the Exchange about Board Meeting to be held on 09-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 09 Nov 2026, 5:30 am
To consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and half year ended on September 30, 2026
Intimation · 09 Nov 2026, 5:30 am
Park Medi World Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2026 ,inter alia, to consider and approve the standalone and consolidated ....
Intimation · 09 Nov 2026, 5:30 am
Park Medi World Schedules Board Meeting for Q2 FY27 Results Park Medi World Limited has scheduled its Board of Directors meeting on 9th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in the company’s securities remains closed for all designated persons and their immediate relatives until the close of business hours on 11th Nov'26, in compliance with SEBI insider trading regulations.
Meeting with Analysts/Investors
Intimation · 02 Nov 2026, 8:37 pm
Park Medi World to Attend Avendus Spark INDX Investor Conference Park Medi World Limited announced that its management will participate in the Avendus Spark INDX: Annual Investor Conference on 16th Nov'26 in Mumbai at the Grand Hyatt, Kalina, starting from 12:00 p.m. onwards. The physical interaction will encompass both one-on-one and group meetings with analysts and investors. The company confirmed that no unpublished price-sensitive information (UPSI) will be discussed during these sessions.
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 23 Oct 2026, 2:45 pm
Park Medi World Limited Discloses Completion of Income Tax Verification Park Medi World Limited reported that the Income Tax Department conducted a verification across certain premises of the company, its subsidiaries, and officials from 12th Oct'26 to 17th Oct'26. The company confirmed there is no quantifiable financial impact and no disruption to its ongoing operations, commitments, or future expansion plans.
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 14 Oct 2026, 2:53 pm
Park Medi World Clarifies Income Tax Department Verification Has No Operational Impact Park Medi World Limited disclosed on 14th Oct'26 that the Income Tax Department conducted verification proceedings across select premises of the company and certain subsidiaries. Company and subsidiary officials cooperated fully with the tax authorities during the exercise. Management confirmed that the verification has had no impact on the company's operational performance.
Voting Results and Consolidated Scrutinizer''s Report on E-voting at 15th Annual General Meeting held on September 22, 2026
Annual General Meeting · 22 Sept 2026, 11:31 pm
Summary of the proceedings of 15th Annual General Meeting of the Company held on September 22, 2026
Annual General Meeting · 22 Sept 2026, 11:13 pm
Press Release titled Park Group of Hospitals Wins Three Honours at Healthcare Pioneers of Delhi 2026
Press Release · 22 Sept 2026, 2:56 pm
Park Medi World Wins Three Industry Honours and Outlines Expansion to ~6,600 Beds Park Medi World Limited was felicitated with three awards at Healthcare Pioneers of Delhi 2026 on 20th Sep'26, including honours for leadership and medical technology excellence. As North India’s second-largest hospital chain, the company currently operates 17 hospitals with ~4,300 beds across 15 key cities. The group is integrating six additional hospitals and expanding capacity at three existing units, which will add 2,300 beds and scale total network capacity to ~6,600 beds, further deepening its presence across Punjab, Uttar Pradesh, and Haryana.
Cancellation of Schedule of Investor/Analyst Meeting
Intimation · 16 Sept 2026, 9:52 pm
Park Medi World Cancels Attendance at Anand Rathi Annual Flagship Conference Park Medi World Limited announced that due to business exigencies, its management will not participate in the Anand Rathi Annual Flagship Conference G-200 Summit 2026 scheduled for 21st Sep'26. The company confirmed that all other scheduled investor conferences previously disclosed on 5th Sep'26 remain unchanged.
Wholly-owned subsidiary of the Company has entered into operation and management agreement with Axis Educational Society
Others (Uncategorized) · 16 Sept 2026, 3:50 pm
Park Medi World Expands Into Kanpur via 28-Year Asset-Light O&M Agreement Park Medi World Limited's wholly owned subsidiary, Aggarwal Hospital and Research Services, signed a 28-year Operation and Management agreement on 16th Sep'26 with Axis Educational Society to operate a 300-bed multi-super speciality hospital in Kanpur, UP. The facility will be commissioned by FY-end. Consideration involves a 6% revenue share with a minimum guarantee of INR 20 lakh per month (inclusive of GST in year one, plus GST thereafter). The deal strengthens the Group’s asset-light footprint, expanding total pipeline capacity toward ~6,600 beds.
Incorporation of Wholly Owned Subsidiary
Others (Uncategorized) · 09 Sept 2026, 1:23 am
Park Medi World Incorporates Subsidiary for Prayagraj PPP Hospital Project Park Medi World Limited incorporated a wholly owned subsidiary, Park Medicity Prayagraj Limited, on 8th Sep'26. The company will hold 100% equity through a cash investment of Rs 0.15 crore, comprising 1,50,000 equity shares at Rs 10 each. The newly formed entity will develop and operate a 550-bed multi-super-speciality hospital in Prayagraj, Uttar Pradesh, awarded to the company under a Public-Private Partnership model by the Prayagraj Municipal Corporation.
Meeting with Analysts/Investors
Intimation · 05 Sept 2026, 9:01 pm
Park Medi World Schedules Multiple Investor Conferences in Sep'26 Park Medi World Limited announced management participation across four investor conferences in Sep'26. The schedule includes in-person meetings at the Kotak Healthcare Forum on 17th Sep'26 and Anand Rathi Annual Flagship Conference G-200 Summit on 21st Sep'26 in Mumbai. Virtual group meetings follow with Kotak Securities on 23rd Sep'26 and Arihant Capital’s Bharat Connect Conference-Rising Stars on 28th Sep'26. The company confirmed no unpublished price-sensitive information will be discussed during these interactions.
Incorporation of Wholly Owned Subsidiary
Others (Uncategorized) · 31 Aug 2026, 4:49 pm
Park Medi World Incorporates SPV for New 550-Bed Hospital in Prayagraj Park Medi World's Board approved the incorporation of a new wholly-owned subsidiary on 31 Aug'26 to execute a key project. The subsidiary, a Special Purpose Vehicle (SPV), will develop and operate a 550-bed multi-super-speciality hospital in Prayagraj, Uttar Pradesh. This project was awarded under a Public-Private Partnership (PPP) model. Park Medi will invest INR 0.15 crore for 100% shareholding, acquiring 1,50,000 equity shares at a face value of INR 10 each in the new entity, named "Park Medicity Prayagraj Limited".
Outcome of Board Meeting held on August 31, 2026
Others (Uncategorized) · 31 Aug 2026, 4:47 pm
Park Medi World To Form SPV for 550-Bed Prayagraj Hospital Project Park Medi World’s Board approved on 31 Aug'26 the incorporation of a wholly-owned subsidiary to act as a Special Purpose Vehicle (SPV) for its new project. The SPV, named "Park Medicity Prayagraj Limited," will develop and operate a 550-bed multi-super-speciality hospital in Prayagraj, Uttar Pradesh. This project was awarded under a Public-Private Partnership model. The company will invest INR 0.15 crore for 1,50,000 equity shares at a face value of Rs 10 each to hold 100% of the new entity.
Letter to the Shareholders containing weblink of Annual Report and Notice of AGM for the Financial year 2025-2026
Annual General Meeting · 28 Aug 2026, 6:53 pm
Annual Report for the Financial Year 2025-2026
Others (Uncategorized) · 28 Aug 2026, 6:46 pm
Notice of 15th Annual General Meeting scheduled on Tuesday, September 22, 2026 at 11:00 am. through VC/OAVM
Annual General Meeting · 28 Aug 2026, 6:36 pm
Intimation regarding Capacity Addition
Others (Uncategorized) · 26 Aug 2026, 2:54 pm
Park Medi World Wins PPP Mandate for 550-Bed Hospital in Prayagraj Park Medi World has been awarded a mandate by Prayagraj Municipal Corporation to develop and operate a 550-bed hospital under a Public-Private Partnership model. The project requires an investment of ~INR 200 crore, financed via internal accruals, with a state government concession of INR 76.52 crore. Construction will take two years, followed by a 45-year lease. This is the company's third project in Uttar Pradesh, increasing its total capacity in the state to 1,260 beds post-completion and reinforcing its North India expansion strategy.
Meeting with Analyst/Investors
Intimation · 18 Aug 2026, 4:19 pm
Park Medi World to Meet With Divitiae Investments on Aug 22 Park Medi World Limited (PARKHOSPS) has announced a virtual group meeting with investors scheduled for 22 Aug'26, starting at 11:00 a.m. The exclusive investor session is organized by Divitiae Investments. According to the 18 Aug'26 filing, the company's management will participate but does not intend to disclose any unpublished price-sensitive information during the conference. The schedule remains subject to change.
Transcript of Earnings Conference Call held on August 04, 2026
Transcript · 08 Aug 2026, 9:25 pm
Schedule of Analyst/ Investor Meetings
Intimation · 05 Aug 2026, 9:30 pm
Park Medi World Limited Management to Attend August 2026 Investor Conferences Park Medi World Limited's management will participate in several analyst and investor conferences in Aug'26. The company will attend the Emkay Confluence 2026 on Aug 12, the Equirus Annual India Conference 26 on Aug 13, and the Antique Healthcare Investor Conference on Aug 25. All meetings are physical, group/one-on-one sessions scheduled to take place in Mumbai. The company stated no unpublished price-sensitive information will be discussed.
Audio recording for the Earnings Conference Call held today i.e. August 04, 2026
Audio / Video · 04 Aug 2026, 6:16 pm
Park Medi World Makes Q1FY27 Earnings Call Recording Available Park Medi World Limited has made the audio recording of its earnings conference call, held on 04 Aug'26, available on its corporate website. The call discussed the unaudited standalone and consolidated financial results for the quarter ended 30 Jun'26. The recording is accessible in the investor relations section of the company's website.
Monitoring Agency Report for the Quarter ended June 30, 2026
Others (Uncategorized) · 03 Aug 2026, 10:47 pm
Park Medi World: IPO Proceeds Utilization Report for Q1 FY27 CRISIL's monitoring report for Q1 FY27 (quarter ended Jun 30, '26) shows Park Medi World has utilized ₹7,051.68 million (91.6%) of its gross IPO proceeds of ₹7,700 million. During the quarter, ₹28.66 million was used for construction of the new Rohtak hospital. As of quarter-end, ₹648.32 million remains unutilized, held in bank balances. The report notes a delay in capital expenditure for medical equipment, originally planned for FY26, attributing it to deferred procurement and negotiations; these funds will be utilized subsequently.